Enanta Pharmaceuticals, Inc. (ENTA) Balance Sheet
ENTA balance sheet, FY2025
September 30, 2025 · U.S. dollars$280.7M assets = $216.0M liabilities + $64.7M equity
Both columns are drawn to the same scale: what ENTA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ENTA financial health
Descriptive bands, not a rating. Fiscal FY2025.
ENTA balance sheet trends, FY2016–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $281.3MFY2016 | $280.7MFY2025 | −0.0%/yr | |
| Total liabilities | $11.3MFY2016 | $216.0MFY2025 | +38.7%/yr | |
| Shareholders’ equity | $269.9MFY2016 | $64.7MFY2025 | −14.7%/yr | |
| Cash & short-term investments | $210.1MFY2016 | $188.9MFY2025 | −1.2%/yr | |
| Total debt | $690,000FY2016 | $201.1MFY2025 | +87.9%/yr | |
| Net cash (debt) | $209.4MFY2016 | −$12.2MFY2025 | −$221.6M | |
| Working capital | $224.3MFY2016 | $155.8MFY2025 | −$68.5M | |
| Book value per share | $14.04FY2016 | $3.03FY2025 | −15.7%/yr | |
| Current ratio | 29.43FY2016 | 4.21FY2025 | −25.22 | |
| Debt / equity | 0.00FY2016 | 3.11FY2025 | +3.10 | |
| Shares outstanding | 19.2MFY2016 | 21.3MFY2025 | +1.2%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ENTA assets
ENTA liabilities and equity
ENTA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ENTA balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $188.9M | $248.2M | $369.9M | $249.2M | $244.0M | $386.6M | $335.2M | $308.7M | $223.7M | $210.1M |
| Cash & equivalents | $32.3M | $37.2M | $85.4M | $44.0M | $57.2M | $87.1M | $51.2M | $63.9M | $65.7M | $16.6M |
| Short-term investments | $156.6M | $211.0M | $284.5M | $205.2M | $186.8M | $299.5M | $284.0M | $244.8M | $158.0M | $193.5M |
| Receivables | $6.9M | $38.6M | $39.6M | $49.0M | $60.8M | $23.5M | $51.3M | $67.2M | $10.6M | $12.8M |
| Inventory | $0 | $0 | $0 | $0 | −$37.3M | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $8.6M | $13.0M | $13.3M | $13.4M | $51.4M | $26.7M | $15.3M | $4.5M | $3.5M | $9.2M |
| Total current assets | $204.3M | $299.9M | $422.8M | $311.7M | $319.0M | $436.8M | $401.8M | $380.4M | $237.8M | $232.2M |
| Property, plant & equipment (net) | $72.9M | $73.3M | $34.7M | $29.7M | $10.7M | $15.6M | $10.9M | $8.4M | $8.0M | $8.0M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $29.3M | $108.4M | $32.6M | $65.0M | $16.4M | $70.0M | $32.1M |
| Other non-current assets | $3.5M | $3.5M | $4.8M | $9.8M | $2.8M | $5.7M | $12.0M | $9.1M | $10.7M | $9.0M |
| Total assets | $280.7M | $376.7M | $462.3M | $380.6M | $440.9M | $490.8M | $489.8M | $414.2M | $326.6M | $281.3M |
| Liabilities | ||||||||||
| Accounts payable | $1.9M | $8.0M | $4.1M | $6.0M | $9.5M | $5.7M | $6.7M | $4.7M | $3.7M | $3.4M |
| Short-term debt | $33.9M | $36.0M | $5.3M | $2.9M | $4.2M | $4.3M | — | — | $79,000 | $73,000 |
| Deferred revenue | — | — | $18.3M | — | — | — | — | — | $9.3M | — |
| Total current liabilities | $48.6M | $57.5M | $62.8M | $29.8M | $36.2M | $24.2M | $22.6M | $16.0M | $21.0M | $7.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $1.8M | $1.9M | $1.1M | $617,000 |
| Lease obligations | $57.9M | $55.5M | $26.5M | $25.3M | $5.3M | $8.1M | $200,000 | $293,000 | $458,000 | $531,000 |
| Other long-term liabilities | $167.5M | $190.3M | $182.8M | $29.4M | $5.3M | $11.1M | $2.9M | $2.6M | $2.8M | $2.8M |
| Total liabilities | $216.0M | $247.8M | $245.5M | $59.3M | $41.4M | $35.2M | $27.3M | $20.5M | $25.0M | $11.3M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $214,000 | $212,000 | $211,000 | $208,000 | $202,000 | $201,000 | $197,000 | $194,000 | $191,000 | $190,000 |
| Retained earnings (deficit) | −$404.9M | −$323.0M | −$207.0M | −$73.2M | $48.6M | $127.6M | $163.7M | $117.4M | $45.4M | $27.6M |
| Treasury stock | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Accumulated other comprehensive income | −$339,000 | $302,000 | −$1.2M | −$3.7M | −$382,000 | $844,000 | $146,000 | −$398,000 | −$112,000 | $19,000 |
| Minority interest | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Total shareholders' equity | $64.7M | $128.8M | $216.7M | $321.3M | $399.4M | $455.6M | $462.5M | $393.7M | $301.7M | $269.9M |
| Key figures | ||||||||||
| Total debt | $201.1M | $226.1M | $26.5M | $26.7M | $6.8M | $9.6M | $200,000 | $293,000 | $1.2M | $690,000 |
| Net cash (debt) | −$12.2M | $22.1M | $343.4M | $222.5M | $237.2M | $377.1M | $335.0M | $308.4M | $222.4M | $209.4M |
| Working capital | $155.8M | $242.3M | $360.0M | $281.9M | $282.8M | $412.7M | $379.2M | $364.4M | $216.8M | $224.3M |
| Tangible book value | $64.7M | $128.8M | $216.7M | $321.3M | $399.4M | $455.6M | $462.5M | $393.7M | $301.7M | $269.9M |
| Book value per share | $3.03 | $6.09 | $10.34 | $15.60 | $19.80 | $22.85 | $22.06 | $19.06 | $15.54 | $14.04 |
| Shares outstanding | 21.3M | 21.2M | 21.0M | 20.6M | 20.2M | 19.9M | 21.0M | 20.6M | 19.4M | 19.2M |
| Current ratio | 4.21 | 5.21 | 6.73 | 10.45 | 8.82 | 18.08 | 17.77 | 23.74 | 11.33 | 29.43 |
| Quick ratio | 4.03 | 4.99 | 6.52 | 10.00 | 8.43 | 16.98 | 17.10 | 23.46 | 11.17 | 28.26 |
| Debt / equity | 3.11 | 1.75 | 0.12 | 0.08 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity / assets | 23.1% | 34.2% | 46.9% | 84.4% | 90.6% | 92.8% | 94.4% | 95.0% | 92.4% | 96.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $189.5M | $163.8M | $185.8M | $188.9M | $204.1M | $193.4M | $216.7M | $248.2M | $230.1M | $300.3M | $337.2M | $369.9M |
| Cash & equivalents | $33.4M | $34.9M | $37.4M | $32.3M | $44.8M | $60.2M | $84.3M | $37.2M | $35.8M | $63.5M | $39.9M | $85.4M |
| Short-term investments | $156.1M | $128.8M | $148.4M | $156.6M | $159.3M | $133.2M | $132.3M | $211.0M | $194.3M | $236.8M | $297.2M | $284.5M |
| Receivables | $6.5M | $7.8M | $8.5M | $6.9M | $8.4M | $40.6M | $40.2M | $38.6M | $40.6M | $39.8M | $39.9M | $39.6M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $1 | $1 | $0 |
| Other current assets | $7.6M | $6.8M | $4.3M | $8.6M | $10.2M | $8.9M | $11.3M | $13.0M | $15.9M | $10.9M | $13.2M | $13.3M |
| Total current assets | $203.6M | $178.4M | $198.7M | $204.3M | $222.7M | $242.9M | $268.1M | $299.9M | $286.6M | $351.0M | $390.3M | $422.8M |
| Property, plant & equipment (net) | $67.8M | $69.5M | $71.3M | $72.9M | $74.9M | $76.7M | $77.0M | $73.3M | $66.3M | $58.4M | $33.5M | $34.7M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $22.0M | $63.2M | $56.1M | $0 | $0 | $0 | $0 | $0 | $42.5M | $0 | $0 | $0 |
| Other non-current assets | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $4.2M | $4.7M | $4.8M |
| Total assets | $296.9M | $314.7M | $329.5M | $280.7M | $301.0M | $323.0M | $348.6M | $376.7M | $398.8M | $413.6M | $428.5M | $462.3M |
| Liabilities | ||||||||||||
| Accounts payable | $3.3M | $4.4M | $1.9M | $1.9M | $3.5M | $4.8M | $4.7M | $8.0M | $10.7M | $6.7M | $9.3M | $4.1M |
| Short-term debt | $3.9M | $35.2M | $35.3M | $33.9M | $30.1M | $32.9M | $33.7M | $36.0M | $34.7M | $37.3M | $46.4M | $40.4M |
| Deferred revenue | — | — | — | — | — | — | — | — | — | — | $11.6M | $18.3M |
| Total current liabilities | $54.2M | $46.4M | $44.7M | $48.6M | $44.5M | $45.9M | $49.0M | $57.5M | $58.2M | $54.6M | $62.4M | $62.8M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $55.7M | $56.5M | $57.1M | $57.9M | $58.0M | $58.7M | $57.5M | $55.5M | $50.6M | $47.0M | $25.5M | $26.5M |
| Other long-term liabilities | $141.6M | $151.7M | $158.2M | $167.5M | $177.2M | $183.5M | $187.8M | $190.3M | $191.7M | $192.8M | $174.2M | $182.8M |
| Total liabilities | $195.8M | $198.1M | $202.9M | $216.0M | $221.8M | $229.5M | $236.8M | $247.8M | $249.9M | $247.4M | $236.6M | $245.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $291,000 | $291,000 | $290,000 | $214,000 | $214,000 | $214,000 | $213,000 | $212,000 | $212,000 | $212,000 | $212,000 | $211,000 |
| Retained earnings (deficit) | −$449.5M | −$430.0M | −$416.9M | −$404.9M | −$386.2M | −$368.0M | −$345.3M | −$323.0M | −$294.2M | −$271.6M | −$240.4M | −$207.0M |
| Accumulated other comprehensive income | −$927,000 | −$734,000 | −$329,000 | −$339,000 | −$402,000 | −$224,000 | −$29,000 | $302,000 | −$653,000 | −$667,000 | −$534,000 | −$1.2M |
| Total shareholders' equity | $101.1M | $116.6M | $126.6M | $64.7M | $79.3M | $93.5M | $111.8M | $128.8M | $148.9M | $166.1M | $191.9M | $216.7M |
| Key figures | ||||||||||||
| Total debt | $55.7M | $186.6M | $193.2M | $201.1M | $207.1M | $216.1M | $221.3M | $226.1M | $226.2M | $229.9M | $220.0M | $222.4M |
| Net cash (debt) | $133.8M | −$22.8M | −$7.3M | −$12.2M | −$3.0M | −$22.8M | −$4.6M | $22.1M | $3.9M | $70.4M | $117.1M | $147.5M |
| Working capital | $149.5M | $132.0M | $154.0M | $155.8M | $178.2M | $196.9M | $219.1M | $242.3M | $228.4M | $296.4M | $327.9M | $360.0M |
| Tangible book value | $101.1M | $116.6M | $126.6M | $64.7M | $79.3M | $93.5M | $111.8M | $128.8M | $148.9M | $166.1M | $191.9M | $216.7M |
| Book value per share | $3.47 | $4.01 | $4.40 | $3.03 | $3.72 | $4.38 | $5.26 | $6.08 | $7.03 | $7.85 | $9.10 | $10.29 |
| Shares outstanding | 29.1M | 29.0M | 28.7M | 21.4M | 21.3M | 21.4M | 21.2M | 21.2M | 21.2M | 21.2M | 21.1M | 21.1M |
| Current ratio | 3.76 | 3.84 | 4.44 | 4.21 | 5.00 | 5.29 | 5.47 | 5.21 | 4.92 | 6.43 | 6.25 | 6.73 |
| Quick ratio | 3.62 | 3.69 | 4.34 | 4.03 | 4.77 | 5.09 | 5.24 | 4.99 | 4.65 | 6.23 | 6.04 | 6.52 |
| Debt / equity | 0.55 | 1.60 | 1.53 | 3.11 | 2.61 | 2.31 | 1.98 | 1.75 | 1.52 | 1.38 | 1.15 | 1.03 |
| Equity / assets | 34.0% | 37.0% | 38.4% | 23.1% | 26.3% | 29.0% | 32.1% | 34.2% | 37.3% | 40.2% | 44.8% | 46.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed November 19, 2025); data from EODHD.
ENTA financial position
At the end of fiscal 2025 (September 30, 2025), Enanta Pharmaceuticals had total assets of $280.7 million (down 25.5% from a year earlier), total liabilities of $216.0 million and shareholders' equity of $64.7 million. It held $188.9 million in cash and short-term investments against $201.1 million of debt, net debt of $12.2 million. Its current ratio was 4.21. In the latest quarter (ended June 30, 2026) total assets were $296.9 million and equity $101.1 million.
Related: ENTA income statement, ENTA cash flow statement, ENTA key metrics. See the ENTA stock overview for the latest quote and news.
ENTA balance sheet FAQ
What are Enanta Pharmaceuticals's total assets?
Enanta Pharmaceuticals reported total assets of $280.7 million at the end of fiscal 2025 (September 30, 2025), compared with $376.7 million a year earlier.
How much debt does Enanta Pharmaceuticals have?
Enanta Pharmaceuticals had $201.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 3.11.
How much cash does Enanta Pharmaceuticals have?
Enanta Pharmaceuticals held $188.9 million in cash and short-term investments at the end of fiscal 2025; with $201.1 million of debt that is net debt of $12.2 million.
What is Enanta Pharmaceuticals's book value?
Enanta Pharmaceuticals's shareholders' equity (book value) was $64.7 million at the end of fiscal 2025, or $3.03 per share.
What is Enanta Pharmaceuticals's current ratio?
Enanta Pharmaceuticals had current assets of $204.3 million and current liabilities of $48.6 million, a current ratio of 4.21 (it can cover its short-term obligations).